NCCI's Annual Insights Symposium takes the stage next week, and we were lucky to borrow some time from Jon Sinclair, who will be presenting If Not Opioids, Then What? on May 14 at 10:45 a.m. EDT. Here's […]
By: Christina Klemm, Pharm.D., BCACP, Clinical Pharmacist, Enlyte The U.S. Food and Drug Administration (FDA) recently approved Journavx (suzetrigine), a novel non-opioid medication developed by Vertex Pharmaceuticals for the treatment of moderate to severe acute pain in […]
Although it is October, I wanted to remind everyone that September was Pain Awareness Month. Remembering these dedicated months allows us to reflect on conditions that impact the patients and families who are impacted by […]
Sarasota, FL (WorkersCompensation.com) -- OxyContin, developed by Purdue Pharma, emerged as a powerful opioid painkiller with a profound influence on the workers' compensation system. Initially seen as a revolutionary approach to pain management, this drug […]
Sarasota, FL (WorkersCompensation.com) -- The story of Purdue Pharma is deeply intertwined with the workers' compensation community, where its flagship product, OxyContin, has had far-reaching consequences. OxyContin, introduced in the late 1990s, promised revolutionary pain […]
Sarasota, FL (WorkersCompensation.com) – With an increase in life expectancy, as well a surge in the age of workers over the age of 65, the numbers of patients with Osteoarthritis (OA) is rising as well. […]
Washington, DC (WorkersCompensation.com) – Last week, the U.S. Supreme Court blocked Purdue Pharma from going forward with its bankruptcy proceedings, a move President Joe Biden said would offer the Sackler family protections from opioid-related civil […]
By Christina Klemm, Pharm.D., BCACP, Clinical Pharmacist Recently the U.S. Food and Drug Administration (FDA) approved an over-the-counter (OTC) naloxone hydrochloride nasal spray product for treating opioid overdose. For the first time, medication to reverse […]